Chengdu Kanghong Pharmaceutical Co., Ltd. (002773)
Market Open
11 Jun, 06:57
XSHE XSHE Primary ¥
19. 94
-0.07
-0.3498%
¥
28.36B Market Cap
- P/E Ratio
2.4% Div Yield
865,100 Volume
- Eps
¥ 20.01
Previous Close Want to track 002773 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
002773 trading today lower at ¥19.94, a decrease of -0.3498% from yesterday's close, completing a monthly decrease of -4.4104% or -¥0.92. Over the past 12 months, 002773 stock lost -32.9748%.
002773 pays dividends to its shareholders, with the most recent payment made on Jun 09, 2026. The next estimated payment will be in In 11 months on Jun 09, 2027 for a total of ¥0.7.
The last earnings report, released on Apr 23, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.229%, based on the last three reports.
Chengdu Kanghong Pharmaceutical Co., Ltd. has completed 2 stock splits, with the recent split occurring on Jun 06, 2019.
The company's stock is traded on one exchange.
002773 Chart
People also search for
Chengdu Kanghong Pharmaceutical Co., Ltd. (002773) FAQ
What is the stock price today?
The current price is ¥19.94.
On which exchange is it traded?
Chengdu Kanghong Pharmaceutical Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 002773.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 2.4%.
What is its market cap?
As of today, the market cap is 28.36B.
Has Chengdu Kanghong Pharmaceutical Co., Ltd. ever had a stock split?
Chengdu Kanghong Pharmaceutical Co., Ltd. had 2 splits and the recent split was on Jun 06, 2019.
Chengdu Kanghong Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Xiao Ke CEO | XSHE Exchange | CNE1000020C4 ISIN |
| CN Country | 4,462 Employees | 9 Jun 2026 Last Dividend | 8 Jun 2016 Last Split | - IPO Date |
Overview
Chengdu Kanghong Pharmaceutical Group Co., Ltd, founded in 1996, is a prominent pharmaceutical company headquartered in Chengdu, China. The company is dedicated to the research, development, production, and sale of a wide range of pharmaceutical products. With a focus on innovation and quality, Chengdu Kanghong Pharmaceutical Group has established itself as a leader in the Chinese pharmaceutical industry. It specializes in chemical drugs, Chinese medicines, and biological products, and has recently expanded its expertise into developing ophthalmic medical devices, showcasing its commitment to addressing a broad spectrum of healthcare needs.
Products and Services
- Chemical Drugs: Chengdu Kanghong Pharmaceutical Group manufactures a wide array of chemical drugs intended for various therapeutic uses. These drugs are developed through rigorous research and comply with stringent quality standards to ensure efficacy and safety for patients.
- Chinese Medicines: Leveraging the rich heritage of traditional Chinese medicine, the company produces formulations derived from natural herbs and ingredients. These products are designed to offer alternative and complementary therapeutic benefits, focusing on holistic well-being and balance.
- Biological Products: The company's portfolio includes biological products that are developed using advanced biotechnological processes. These products aim to meet the growing demand for biologically derived medications, offering innovative treatments for a range of conditions.
- Ophthalmic Medical Devices: Expanding its product range, Chengdu Kanghong Pharmaceutical Group also develops medical devices specifically designed for ophthalmic use. These devices are aimed at enhancing the diagnosis and treatment of eye-related diseases, demonstrating the company's commitment to diversifying its offerings and improving patient care in the field of ophthalmology.
- Central Nervous System Drugs: The company offers a variety of drugs targeting disorders of the central nervous system. These medications are crafted to treat conditions affecting the brain and spinal cord, contributing to the improvement of mental health and neurological functions.
- Digestive System Drugs: Addressing the needs of the digestive tract, Chengdu Kanghong Pharmaceutical Group provides drugs designed to treat various digestive system disorders. The focus is on ensuring the effective management and relief of gastrointestinal conditions.
- Endocrine System Drugs: The company also specializes in producing drugs for treating endocrine system disorders. These medications aim to restore hormonal balance and support the health of the endocrine glands, which play a crucial role in the body's metabolic functions.
Contact Information
Address: No 108, Shuxi Road, Chengdu, China, 610037
Phone: 86 28 8750 2055
Website: https://www.cnkh.com
